Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNAs as Bile-based biomarkers in pancreaticobiliary cancers (MIRABILE): a cohort study

23 Jul 2024

Abstract excerpt

BACKGROUND: Biliary obstruction can be due to both malignant and benign pancreaticobiliary disease. Currently, there are no biomarkers that can accurately help make this distinction. MicroRNAs (miRNAs) are stable molecules in tissue and biofluids that are commonly deregulated in cancer. The MIRABILE study aimed to identify miRNAs in bile that can differentiate malignant from benign pancreaticobiliary disease....

Topics

Join the communities discussing this publication.

Gallbladder and Bile Duct Disorders
Pancreatitis Pathology and Treatment
Pediatric Hepatobiliary Diseases and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39041944
DOI: 10.1097/js9.0000000000001888

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs as Bile-based biomarkers in pancreaticobiliary cancers (MIRABILE): a cohort studyPMID 39041944Read ↗

MicroRNAs as bile-based biomarkers for pancreatic and biliary-tract cancersSemantic proximity Read ↗

Micro-RNA in Cholangiocarcinoma: Implications for Diagnosis, Prognosis, and TherapySemantic proximity Read ↗

Circulating microRNAs as biomarkers in bile-derived exosomes of cholangiocarcinomaSemantic proximity Read ↗

Real-Time PCR-Based Analysis of the Human Bile MicroRNAome Identifies miR-9 as a Potential Diagnostic Biomarker for Biliary Tract CancerSemantic proximity Read ↗

MicroRNAs in biliary diseases.Semantic proximity Read ↗

Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary stricturesSemantic proximity Read ↗

Integrating multi-omics in bile for biomarker discovery in cholangiocarcinomaSemantic proximity Read ↗

Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAsSemantic proximity Read ↗

Biomarkers for the Management of Cholangiocarcinoma: Unveiling New Horizons for Precision TherapySemantic proximity Read ↗

Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancerSemantic proximity Read ↗

An integrated multi-omics biomarker approach using molecular profiling and microRNAs for evaluation of pancreatic cyst fluid.Semantic proximity Read ↗

MicroRNAs in acute pancreatitis: From pathogenesis to novel diagnosis and therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.